These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27112206)

  • 1. Genetics: p53 variant increases cancer risk.
    Seton-Rogers S
    Nat Rev Cancer; 2016 Apr; 16(5):273. PubMed ID: 27112206
    [No Abstract]   [Full Text] [Related]  

  • 2. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?
    Sousa H; Santos AM; Pinto D; Medeiros R
    Acta Med Port; 2011; 24(1):127-34. PubMed ID: 21672450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women.
    Singh V; Rastogi N; Mathur N; Singh K; Singh MP
    Ann Epidemiol; 2008 Jan; 18(1):48-57. PubMed ID: 17719241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.
    Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K
    Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population.
    Ma H; Hu Z; Zhai X; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wang X; Wei Q; Shen H
    Carcinogenesis; 2006 Apr; 27(4):766-71. PubMed ID: 16314399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 intronic G13964C variant in colon cancer and its association with HPV.
    Buyru N; Tezol A; Dalay N
    Anticancer Res; 2005; 25(4):2767-9. PubMed ID: 16080524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is p53 intronic variant G13964C associated with predisposition to cancer?
    Fiszer-Maliszewska Ł; Kazanowska B; Kuśnierczyk P; Mańczak M; Niepiekło W; Pochroń-Zeman B; Nowakowska B
    J Appl Genet; 2003; 44(4):547-52. PubMed ID: 14617836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status.
    Xu Y; Yao L; Zhao A; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lu Y; Xie Y
    Int J Cancer; 2008 Jun; 122(12):2761-6. PubMed ID: 18348141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of breast cancer outcome with status of p53 and MDM2 SNP309.
    Boersma BJ; Howe TM; Goodman JE; Yfantis HG; Lee DH; Chanock SJ; Ambs S
    J Natl Cancer Inst; 2006 Jul; 98(13):911-9. PubMed ID: 16818855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
    Prodosmo A; Buffone A; Mattioni M; Barnabei A; Persichetti A; De Leo A; Appetecchia M; Nicolussi A; Coppa A; Sciacchitano S; Giordano C; Pinnarò P; Sanguineti G; Strigari L; Alessandrini G; Facciolo F; Cosimelli M; Grazi GL; Corrado G; Vizza E; Giannini G; Soddu S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):135. PubMed ID: 27599564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
    Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
    Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent natural selection identifies a genetic variant in a regulatory subunit of protein phosphatase 2A that associates with altered cancer risk and survival.
    Grochola LF; Vazquez A; Bond EE; Würl P; Taubert H; Müller TH; Levine AJ; Bond GL
    Clin Cancer Res; 2009 Oct; 15(19):6301-8. PubMed ID: 19773383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin resistance conferred by the RAD51D (E233G) genetic variant is dependent upon p53 status in human breast carcinoma cell lines.
    Nadkarni A; Rajesh P; Ruch RJ; Pittman DL
    Mol Carcinog; 2009 Jul; 48(7):586-91. PubMed ID: 19347880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MC1R variant allele effects on UVR-induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture.
    Wong SS; Ainger SA; Leonard JH; Sturm RA
    J Invest Dermatol; 2012 May; 132(5):1452-61. PubMed ID: 22336944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment.
    Atencio IA; Avanzini JB; Johnson D; Neuteboom S; Vaillancourt MT; Nielsen LL; Hajian G; Sutjipto S; Sugarman BJ; Philopena J; McAllister DL; Beltran JC; Nodelman M; Ramachandra M; Wills KN
    Mol Ther; 2001 Jul; 4(1):5-12. PubMed ID: 11472100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism.
    Honda K; Kajitani K; Nobeyama H; Kira Y; Yabunaka Y; Egami M; Zhi X; Fukuda T; Yoshida H; Matsumoto Y; Ichimura T; Yaui T; Sumi T; Ishiko O
    Asian Pac J Cancer Prev; 2011; 12(4):865-8. PubMed ID: 21790217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.